ADAM17 protects mice against elastase-induced emphysema via inactivation of CD62L
S. Suzuki (Tokyo, Japan), M. Ishii (Tokyo, Japan), T. Asakura (Tokyo, Japan), H. Namkoong (Tokyo, Japan), S. Okamori (Tokyo, Japan), K. Yagi (Tokyo, Japan), H. Kamata (Tokyo, Japan), T. Kusumoto (Tokyo, Japan), S. Kagawa (Tokyo, Japan), A. Hegab (Tokyo, Japan), K. Horiuchi (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), T. Betsuyaku (Tokyo, Japan)
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Suzuki (Tokyo, Japan), M. Ishii (Tokyo, Japan), T. Asakura (Tokyo, Japan), H. Namkoong (Tokyo, Japan), S. Okamori (Tokyo, Japan), K. Yagi (Tokyo, Japan), H. Kamata (Tokyo, Japan), T. Kusumoto (Tokyo, Japan), S. Kagawa (Tokyo, Japan), A. Hegab (Tokyo, Japan), K. Horiuchi (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), T. Betsuyaku (Tokyo, Japan). ADAM17 protects mice against elastase-induced emphysema via inactivation of CD62L. 4267
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: